International Journal of Gynecological Cancer

Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study
pp. 955-962(8)
Authors: LONGATTO-FILHO,; ERŽEN,; BRANCA,; ROTELI-MARTINS,; NAUD,; DERCHAIN,; HAMMES,; SARIAN,; BRAGANÇA,; MATOS,; GONTIJO,; LIMA,; MAEDA,; TATTI,; SYRJÄNEN,; DORES,; LÖRINCZ,

Prediction of lymph node metastases in vulvar cancer: a review
pp. 963-971(9)
Authors: OONK,; HOLLEMA,; deHULLU,; van derZEE,

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome
pp. 972-978(7)
Authors: FARATIAN,; STILLIE,; BUSBY-EARLE,; COWIE,; MONAGHAN,

Genetic variation in ABCB1 influences paclitaxel pharmacokinetics in Japanese patients with ovarian cancer
pp. 979-985(7)
Authors: YAMAGUCHI,; HISHINUMA,; ENDO,; TSUKAMOTO,; KISHIKAWA,; SATO,; MURAI,; HIRATSUKA,; ITO,; OKAMURA,; YAEGASHI,; SUZUKI,; TOMIOKA,; GOTO,

Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking
pp. 986-990(5)
Authors: LE,; SHAHRIARI,; HOPKINS,; FAUGHT,; FUNG KEE FUNG,

Extraperitoneal laparoscopic para-aortic lymphadenectomy for lymph node recurrence of fallopian tube carcinoma
pp. 991-993(3)
Authors: CÓRDOBA,; GIL-MORENO,; de laTORRE,; MARTÍNEZ-PALONES,; DÍAZ,; XERCAVINS,

Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy
pp. 994-999(6)
Authors: KASTRITIS,; EFSTATHIOU,; GIKA,; BOZAS,; KOUTSOUKOU,; PAPADIMITRIOU,; PISSAKAS,; DIMOPOULOS,; BAMIAS,

Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms
pp. 1000-1006(7)
Authors: CHO,; CHOI,; CHAE,; SOHN,; AHN,

The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population
pp. 1007-1013(7)
Authors: INOUE,; SAKAGUCHI,; SASAGAWA,; TANGO,

Implications regarding atypical squamous cells of undetermined significance among women residing in a US-Mexico border city
pp. 1014-1016(3)
Authors: GREENBERG,; DUARTE-GARDEA,; QUEZADA,

Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia
pp. 1017-1024(8)
Authors: STEVENS,; TABRIZI,; QUINN,; GARLAND,

Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients
pp. 1025-1031(7)
Authors: TAWFIK EL-MANSI,; CUSCHIERI,; MORRIS,; WILLIAMS,

Serologic response to human papillomavirus 16 among Australian women with high-grade cervical intraepithelial neoplasia
pp. 1032-1035(4)
Authors: TABRIZI,; FRAZER,; GARLAND,

Reduction in prevalence of invasive cervical cancer in KwaZulu-Natal, South Africa: impact of the human immunodeficiency virus epidemic
pp. 1036-1040(5)
Author: MOODLEY,

Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions
pp. 1041-1047(7)
Authors: PIÑA-SÁNCHEZ,; HERNÁNDEZ-HERNÁNDEZ,; LÓPEZ-ROMERO,; VÁZQUEZ-ORTÍZ,; PÉREZ-PLASENCIA,; LIZANO-SOBERÓN,; GONZÁLEZ-SÁNCHEZ,; CRUZ-TALONIA,; SALCEDO,

Human papillomavirus prevalence in postradiotherapy uterine cervical carcinoma patients: correlation with recurrence of the disease
pp. 1048-1054(7)
Authors: SINGH,; MAULIK,; MITRA,; MONDAL,; BASU,; ROYCHOWDHURY,; PANDA,

Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities
pp. 1055-1062(8)
Authors: deOLIVEIRA,; DERCHAIN,; SARIAN,; RABELO-SANTOS,; GONTIJO,; YOSHIDA,; ANDRADE,; ZEFERINO,

An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution
pp. 1063-1068(6)
Authors: GHARORO,; IKEANYI,

Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology
pp. 1069-1074(6)
Authors: SIEBERS,; VERBEEK,; MASSUGER,; GREFTE,; BULTEN,

Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial
pp. 1075-1081(7)
Authors: FIANDER,; TRISTRAM,; DAVIDSON,; TOMLINSON,; MAN,; BALDWIN,; STERLING,; KITCHENER,

Outcomes of loop electrosurgical excision procedure for cervical neoplasia in human immunodeficiency virus-infected women
pp. 1082-1088(7)
Authors: KIETPEERAKOOL,; SRISOMBOON,; SUPRASERT,; PHONGNARISORN,; CHAROENKWAN,; CHEEWAKRIANGKRAI,; SIRIAREE,; TANTIPALAKORN,; PANTUSART,

Psychologic morbidities prior to loop electrosurgical excision procedure in the treatment of cervical intraepithelial neoplasia
pp. 1089-1093(5)
Authors: LE,; HOPKINS,; MENARD,; HICKS-BOUCHER,; LEFEBVRE,; FUNG KEE FUNG,

The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy
pp. 1094-1100(7)
Authors: OGINO,; NAKAYAMA,; OKAMOTO,; KITAMURA,; INOUE,

High-dose rate brachytherapy in the treatment of carcinoma of uterine cervix: twenty-year experience with cobalt after-loading system
pp. 1101-1105(5)
Authors: MOSALAEI,; MOHAMMADIANPANAH,; OMIDVARI,; AHMADLOO,

Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix
pp. 1106-1111(6)
Authors: EIFEL,; JHINGRAN,; BROWN,; LEVENBACK,; THAMES,

Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study
pp. 1112-1118(7)
Authors: PIETERSE,; TRIMBOS,; DIJKMAN,; CREUTZBERG,; GAARENSTROOM,; PETERS,; KENTER,

An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer
pp. 1119-1129(11)
Authors: PIETERSE,; MAAS,; TER KUILE,; LOWIK,; VANEIJKEREN,; TRIMBOS,; KENTER,

Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls
pp. 1130-1139(10)
Authors: BERGMARK,; ÅVALL-LUNDQVIST,; DICKMAN,; HENNINGSOHN,; STEINECK,

Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice
pp. 1140-1146(7)
Authors: WHITE,; FAITHFULL,

Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma
pp. 1147-1151(5)
Authors: MICHA,; GOLDSTEIN,; RETTENMAIER,; BROWN,; JOHN,; MARKMAN,

Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer
pp. 1152-1156(5)
Authors: SERKIES,; JASSEM,; DZIADZIUSZKO,

Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix
pp. 1157-1164(8)
Authors: CHOI,; KIM,; LEE,; BAE,

Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer
pp. 1165-1171(7)
Authors: MALUF,; LEISER,; AGHAJANIAN,; SABBATINI,; PEZZULLI,; CHI,; WOLF,; LEVENBACK,; LOH,; SPRIGGS,

Pemetrexed (Alimta^®, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial
pp. 1172-1178(7)
Authors: GOEDHALS,; vanWIYK,; SMITH,; FOURIE,

Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer
pp. 1179-1183(5)
Authors: SINGH,; ORAKWUE,; HONEST,; BALOGUN,; LOPEZ,; LUESLEY,

Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix
pp. 1184-1187(4)
Authors: LEE,; PARK,; CHO,; HA,

Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix
pp. 1188-1194(7)
Authors: FREGNANI,; LATORRE,; NOVIK,; LOPES,; SOARES,

Benign vascular tumors of female genital tract
pp. 1195-1200(6)
Authors: GUPTA,; SINGH,; NIGAM,; KHURANA,

Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina
pp. 1201-1211(11)
Authors: HELLMAN,; LUNDELL,; SILFVERSWÄRD,; NILSSON,; HELLSTRÖM,; FRANKENDAL,

Paget's disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution
pp. 1212-1215(4)
Authors: NIIKURA,; YOSHIDA,; ITO,; TAKANO,; WATANABE,; AIBA,; YAEGASHI,

Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix
pp. 1216-1224(9)
Authors: LIN,; LAI,; CHIOU,; SHUI,; CHANG,; YU,; CHU,

Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system
pp. 1225-1233(9)
Authors: TAWFIK EL-MANSI,; WILLIAMS,

Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics
pp. 1234-1240(7)
Authors: JEONG,; YOUM,; KIM,; LEE,; SUNG,; YOON,

Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract
pp. 1241-1247(7)
Authors: ROOMI,; IVANOV,; KALINOVSKY,; NIEDZWIECKI,; RATH,

X chromosomal and autosomal loss of heterozygosity and microsatellite instability in human cervical carcinoma
pp. 1248-1253(6)
Authors: EDELMANN,; RICHTER,; HÄNEL,; HERING,; HORN,

Evaluation of PTEN expression in cervical adenocarcinoma by tissue microarray
pp. 1254-1260(7)
Authors: EL-MANSI,; WILLIAMS,

Effects of 17β-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines
pp. 1261-1268(8)
Authors: RUUTU,; WAHLROOS,; SYRJÄNEN,; JOHANSSON,

Association between HLA-DQB1 and cervical dysplasia in Vietnamese women
pp. 1269-1277(9)
Authors: LEMA,; FUESSEL-HAWS,; LEWIS,; RADY,; LEE,; TURBAT-HERRERA,; HE,; NGUYEN,; TYRING,; DAO,

Interleukin-6 polymorphisms and the risk of cervical cancer
pp. 1278-1282(5)
Authors: NOGUEIRADESOUZA,; BRENNA,; CAMPOS,; SYRJÄNEN,; BARACAT,; SILVA,

Telomerase activity in the vaginal margins of radical hysterectomy in patients with carcinoma of the cervix: correlation with histology and human papillomavirus
pp. 1283-1288(6)
Authors: TRIGINELLI,; SILVA-FILHO,; TRAIMAN,; SILVA,; CHAVES-DIAS,; OLIVEIRA,; CUNHA-MELO,

A subgroup of HOX Abd-B gene is differentially expressed in cervical cancer
pp. 1289-1296(8)
Authors: LÓPEZ,; GARRIDO,; VÁZQUEZ,; PIÑA,; PÉREZ,; ALVARADO,; SALCEDO,

Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression
pp. 1297-1302(6)
Authors: RAUVALA,; AGLUND,; PUISTOLA,; TURPEENNIEMI-HUJANEN,; HORVATH,; WILLÉN,; STENDAHL,

COX-1 and COX-2 expression in stage I and II invasive cervical carcinoma: relationship to disease relapse and long-term survival
pp. 1303-1308(6)
Authors: ATHAVALE,; CLOONEY,; O'HAGAN,; SHAWKI,; CLARK,; GREEN,

Expression of thymidine phosphorylase as an effect prediction factor for uterine cervical squamous cell carcinoma after radiotherapy: an immunohistochemical study
pp. 1309-1313(5)
Authors: NAKASHIMA,; NAKANO,; AMETANI,; FUNAMOTO,; UCHIYAMA,; MIWA,; MIYATA,; SHOJI,; KONDO,; SATAKE,; KOJIMA,

Hypoxia and expression of the proapoptotic regulator BNIP3 in cervical cancer
pp. 1314-1320(7)
Authors: LEO,; HORN,; HÖCKEL,

Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells
pp. 1321-1329(9)
Authors: YIM,; LEE,; KIM,; PARK,

Statistical analysis of pathologic risk factors for intramyometrial lymphvascular space involvement in myoinvasive endometrial carcinoma
pp. 1330-1335(6)
Authors: HONOR011011011011011011011011011011011011011E011011011011011011011?,; HANSON,

Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes
pp. 1336-1341(6)
Authors: AMEZCUA,; MACDONALD,; LUM,; YI,; MUDERSPACH,; ROMAN,; FELIX,

Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer
pp. 1342-1347(6)
Authors: TASKIRAN,; YUCE,; GEYIK,; KUCUKALI,; AYHAN,

Cholecystectomy and endometrial cancer: a marker of long-term elevated estrogen exposure?
pp. 1348-1353(6)
Authors: MORIMOTO,; NEWCOMB,; HAMPTON,; TRENTHAM-DIETZ,

Loss of p16 in recurrent malignant mixed müllerian tumors of the uterus
pp. 1354-1357(4)
Authors: ROBINSON-BENNETT,; BELCH,; HAN,

Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003)
pp. 1358-1363(6)
Authors: KOKAWA,; NISHIYAMA,; IKEUCHI,; IHARA,; AKAMATSU,; ENOMOTO,; ISHIKO,; MOTOYAMA,; FUJII,; UMESAKI,

Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus
pp. 1364-1369(6)
Authors: WONG,; SEE,; KHOO-TAN,; LOW,; NG,

Use of trastuzumab in the treatment of metastatic endometrial cancer
pp. 1370-1373(4)
Authors: JEWELL,; SECORD,; BROTHERTON,; BERCHUCK,

Serum proteomic features for detection of endometrial cancer
pp. 1374-1378(5)
Authors: ZHU,; ZHANG,; YU,; ZHENG,; LIAO,

Combined E-cadherin, α-catenin, and β-catenin expression is a favorable prognostic factor in endometrial carcinoma
pp. 1379-1385(7)
Authors: SCHOLTEN,; ALIREDJO,; CREUTZBERG,; SMIT,

Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables
pp. 1386-1392(7)
Authors: HONOR011011011011011011011011011011011011011E011011011011011011011?,; HANSON,; ANDREW,

The detection of microsatellite instability in blind endometrial samples—a potential novel screening tool for endometrial cancer in women from hereditary nonpolyposis colorectal cancer families?
pp. 1393-1400(8)
Authors: HEWITT,; WOOD,; QUINTON,; CHARLTON,; TAYLOR,; SHERIDAN,; DUFFY,

Heparanase expression in both normal endometrium and endometrial cancer
pp. 1401-1406(6)
Authors: *†, HASENGAOWA; KODAMA,; KUSUMOTO,; SEKI,; MATSUO,; OJIMA,; NAKAMURA,; HONGO,; HIRAMATSU,

CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma
pp. 1407-1411(5)
Authors: ESINLER,; AKTAS,; ALIKASIFOGLU,; TUNCBILEK,; AYHAN,

Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium
pp. 1412-1418(7)
Authors: ERKANLI,; KAYASELCUK,; KUSCU,; BAGIS,; BOLAT,; HABERAL,; DEMIRHAN,

MSH2 splice site mutation and endometrial cancer
pp. 1419-1423(5)
Authors: BIANCHI,; ROSATI,; BELVEDERESI,; LORETELLI,; CATALANI,; MANDOLESI,; BRACCI,; BEARZI,; PORFIRI,; CELLERINO,

Targeting topoisomerase IIa in endometrial adenocarcinoma: a combined chromogenic in situ hybridization and immunohistochemistry study based on tissue microarrays
pp. 1424-1431(8)
Authors: TSIAMBAS,; ALEXOPOULOU,; LAMBROPOULOU,; GERONTOPOULOS,; KARAKITSOS,; KARAMERIS,

Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia
pp. 1432-1438(7)
Authors: TURAN,; KARACAY,; TULUNAY,; BORAN,; KOC,; BOZOK,; KOSE,

Hepatoid carcinoma of the ovary: immunohistochemical finding of one case and literature review
pp. 1439-1441(3)
Authors: YİĞİT,; UYAROĞLU,; KUŞ,; EKİNCİ,; ÖZTEKİN,

A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman
pp. 1442-1445(4)
Authors: TAKEUCHI,; KITAZAWA,; HAMANISHI,; INAGAKI,; MURATA,

Endometrial adenocarcinoma following insertion of the levonorgestrel-releasing intrauterine system (mirena) in a 36-year-old woman
pp. 1445-1447(3)
Authors: ABU,; BROWN,; IRELAND,

Intravascular leiomyomatosis and benign metastasizing leiomyoma: an unusual case
pp. 1448-1450(3)
Authors: ARIF,; GANESAN,; SPOONER,

Second case of uterine mesonephric adenocarcinoma
pp. 1450-1454(5)
Authors: MARQUETTE,; MOERMAN,; VERGOTE,; AMANT,

Sentinel node mapping in a pregnant woman with cervical cancer: a case report
pp. 1454-1457(4)
Authors: SILVA,; SILVA-FILHO,; TRAIMAN,; TRIGINELLI,; DELIMA,; SIQUEIRA,; LANA,; CUNHA-MELO,

Malignant pericardial effusion with cardiac tamponade in a patient with metastatic vaginal adenocarcinoma
pp. 1458-1461(4)
Authors: NAGARSHETH,; HARRISON,; KALIR,; RAHAMAN,

Primary vaginal adenocarcinoma of intestinal type arising from a tubulovillous adenoma
pp. 1461-1465(5)
Authors: TJALMA,; COLPAERT,

Malignant eccrine spiradenoma of the vulva: a case report and review of the literature
pp. 1465-1469(5)
Authors: CHASE,; BASU,; SAFFARI,; RIES,; BERMAN,

The problem of accurate initial diagnosis of Bartholin's gland carcinoma resulting in delayed treatment and aggressive course of the disease
pp. 1469-1472(4)
Authors: WYDRA,; KLASA-MAZURKIEWICZ,; EMERICH,; MILCZEK,

Epithelioid trophoblastic tumor: a case report
pp. 1473-1476(4)
Authors: LO,; LOW,; TAN,; BARANYAI,

Extrauterine choriocarcinoma of the greater omentum after tubal pregnancy: case report
pp. 1476-1478(3)
Authors: WAN,; LI,; XIE,

Recurrence in a Schuchardt incision after Schauta-Amreich radical vaginal hysterectomy for cervical cancer
pp. 1479-1481(3)
Authors: BADER,; BJELIC-RADISIC,; TAMUSSINO,; PRISTAUZ,; WINTER,

Management of abnormal uterine hemorrhage with atypical endometrial hyperplasia by transcervical resection of endometrium
pp. 1482-1486(5)
Authors: SUI,; XIE,; CAO,

Letter
pp. 1487-1487(1)

Response to the letter of Soutter and deSouza
pp. 1488-1488(1)

Erratum
pp. 1489-1489(1)